In the news
A collection of 11 posts
DrugBank’s Journey to Fueling Global COVID-19 Antiviral Research
It’s been over a year since COVID-19 emerged and DrugBank has been at the forefront of COVID antiviral research. Our two co-founders, Mike Wilson and Craig Knox, sit down (virtually) with Arden Tse from the Accelerate Fund.
Join us on Kaysen's Quest: Learn more about Gene Therapy, Zolgensma
As a company that specializes in drug information, DrugBank always tries to remain informed about novel treatments, drug approvals, and drugs that are impacting global health. At the top of our minds lately is Zolgensma [https://www.drugbank.ca/drugs/DB15528] (Onasemnogene abeparvovec), a gene therapy indicated for the treatment
Edmonton Startup, DrugBank, Graduates from Creative Destruction Lab - West
May 27, 2020 - Edmonton based startup, DrugBank, recently graduated from the 2019/20 Creative Destruction Lab (CDL) Program. CDL is a seed-stage accelerator program for massively scalable, science-based companies. Its nine-month program pairs founders with experienced entrepreneurs and investors to set focused, measurable objectives with the goal of maximizing
Cannabinoids in Epilepsy: A New Era of Treatments
In a groundbreaking announcement, a Food and Drug Administration (FDA) advisory panel gave their unanimous recommendation in April 2018 for the approval of Epidiolex, a cannabis-derived product shown to be effective for the treatment of two forms of treatment-resistant childhood epilepsies.
Ketamine: the key to treatment resistant depression?
The treatment of depression can be a complex blend of art and science as the pathophysiology remains poorly understood. Here we explore Ketamine, a drug that has proven to have an important place in medicine and a possibly ground-breaking place in treatment of depression.
CFTR Modulators Helping Cystic Fibrosis Patients Catch Their Breath
Orkambi and Kalydeco are members of a new generation of medications that are making history for people living with Cystic Fibrosis. These treatments focus on improving underlying lung function rather than simply delaying its decline...
New Antivirals Provide Hope for Eradication of Hepatitis C – If You Can Afford It
We’ve been lucky enough to find ourselves in the golden age of antivirals. Effective medications for the management of infectious diseases like Hepatitis C and HIV have revolutionized care. Unfortunately, promises of eradication mean nothing if the drug can’t find its way into the hands of patients.